engaged in the Manufacturing, Sales, Research of chemicals and special materials.

Sales & Support
Request A Quote

Home > Products > APIs >

Ticagrelor [274693-27-5]

Browse Categories
APIs [56]
Intermediates [159]
Agrochemicals [58]
Evaporation Materials [19]
Titanium products [13]
Sputtering Targets [19]
Hydroxyapatite [17]
Others Material [119]
Hi , I have tested your Prasugrel and 6-Thioxanthine sample. The testing result is very good. Thanks for your quality product.Regards!

—— Ph.John

Dear Good days! we have very good news, the both samples are fine, the analytical test results meet the requirements of the client, thanks! Regar

—— Fedro

I'm Online Chat Now

Ticagrelor [274693-27-5]

Product Details:

Place of Origin:CHN
Description
Name Ticagrelor
Synonyms AR-C 126532XX; AZD 6140; (1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-1,2-cyclopentanediol
Molecular Formula C23H28F2N6O4S
Molecular Weight 522.57
CAS Registry Number 274693-27-5

 

 

2-(((3aR,4S,6R,6aS)-6-Amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol (2R,3R)-2,3-dihydroxysuccinate 376608-65-0
(3aR,4S,6R,6aS)-6-Amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-ol 155899-66-4
2-(((3aR,4S,6R,6aS)-6-Amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol 274693-55-9
(1R,2S)-2-(3,4-Difluorophenyl)cyclopropanamine (R)-2-hydroxy-2-phenylacetate 376608-71-8
(1R,2S)-2-(3,4-Difluorophenyl)cyclopropanamine 220352-38-5
(1R,2S)-rel-2-(3,4-Difluorophenyl)cyclopropanamine hydrochloride 1156491-10-9
4,6-Dichloro-2-(propylthio)pyrimidin-5-amine 145783-15-9
4,6-Dichloro-5-nitro-2-(propylthio)pyrimidine 145783-14-8

 

 

Ticagrelor, a new platelet aggregation inhibitor successfully developed by AstraZeneca (U.S.), is the world’s first reversible combination orally-administered P2Y12 adenosine diphosphate receptor antagonist.
It is used to reduce cardiovascular death and heart attacks in patients with acute coronary syndrome (ACS.) Rapid onset after oral administration, and can effectively improve symptoms of patients with ACS. Thienopyridines is a reversible P2Y12 inhibitor, so it is particularly applicable towards patients who need to undergo anticoagulant therapy before surgery.

Contact Details
Advanced Material Technologies(KIN GROUP) Co.,Ltd

Contact Person: Mr. Lin Yue

Send your inquiry directly to us (0 / 3000)

Other Products